Surfactants as stabilizers for biopharmaceuticals: An insight into the molecular mechanisms for inhibition of protein aggregation

被引:22
|
作者
Arsiccio, Andrea [1 ]
Pisano, Roberto [1 ]
机构
[1] Politecn Torino, Dept Appl Sci & Technol, 24 Corso Duca Abruzzi, I-10129 Turin, Italy
关键词
Surfactants; Biopharmaceuticals; Aggregation; Molecular dynamics; HUMAN GROWTH-HORMONE; POLYSORBATE; 20; EQUILIBRIUM; PARTICLES; SUCROSE;
D O I
10.1016/j.ejpb.2018.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Surfactants are common stabilizers, often added to biopharmaceuticals formulations, but the mechanisms at the basis of their activity are unclear. The aim of this work is to provide insight into the molecular factors underlying surfactant effectiveness as protectants. Methods: Molecular Dynamics simulations of human growth hormone (hGH) in the presence of Tween 20 were performed. The effect of Tween 20 was compared with the activity of commonly used protectants, such as the disaccharides. Results: We found that Tween 20 could prevent the self-association of hGH, leading to the formation of a protein-surfactant complex. In the case of unfolded hGH, surfactant molecules were oriented with their hydrophilic head in the direction of the protein hydrophobic patches. This created a highly unstable situation, fostering refolding. In the case of native hGH, Tween 20 molecules oriented with their lipophilic groups in the direction of the protein surface. This thermodynamically stabilized the native conformation, preventing unfolding. Conclusions: We found that the ability of surfactants to foster protein refolding is related to their amphiphilic nature, and, more specifically, to their specific orientation with respect to the protein surface. A molecular mechanism explaining surfactant activity is proposed, which could provide direction for improvements in biopreservation.
引用
收藏
页码:98 / 106
页数:9
相关论文
共 50 条
  • [31] Mechanisms of Prion Protein Aggregation
    Fontaine, Sarah N.
    Brown, David R.
    PROTEIN AND PEPTIDE LETTERS, 2009, 16 (01): : 14 - 26
  • [32] A molecular insight into the aggregation of cisplatin in aqueous solutions
    Sami, Reihaneh
    Zolghadr, Amin Reza
    Dokoohaki, Maryam Heydari
    CHEMICAL PHYSICS, 2025, 589
  • [33] Molecular design of surfactants to tailor its aggregation properties
    Bhattacharya, S
    Haldar, J
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2002, 205 (1-2) : 119 - 126
  • [34] Inhibition of Mutant αB Crystallin-Induced Protein Aggregation by a Molecular Tweezer
    Xu, Na
    Bitan, Gal
    Schrader, Thomas
    Klaerner, Frank-Gerrit
    Osinska, Hanna
    Robbins, Jeffrey
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08):
  • [35] A Review On Huntington Protein: Insight Into Protein Aggregation and Therapeutic Interventions
    Srinivasan, Ekambaram
    Ram, Vavish
    Rajasekaran, Ramalingam
    CURRENT DRUG METABOLISM, 2022, 23 (04) : 260 - 282
  • [36] Effect of surfactants on the prevention of protein aggregation during unfolding and refolding processes -: Comparison with molecular chaperone α-crystallin
    Bhattacharyya, J
    Das, KP
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 1999, 20 (04) : 1163 - 1178
  • [37] Molecular mechanisms of feedback inhibition of protein kinase A on intracellular cAMP accumulation
    Vandamme, Jurgen
    Castermans, Dries
    Thevelein, Johan M.
    CELLULAR SIGNALLING, 2012, 24 (08) : 1610 - 1618
  • [38] Unravel molecular mechanisms of G protein inhibition with radioligand binding experiments
    Schrage, R.
    Boedefeld, T.
    Koenig, G.
    Kostenis, E.
    Mohr, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S26 - S26
  • [39] The antiapoptotic actions of mood stabilizers - Molecular mechanisms and therapeutic potentials
    Chuang, DM
    NEUROPROTECTIVE AGENTS, 2005, 1053 : 195 - 204
  • [40] MOLECULAR MECHANISMS OF PLATELET-AGGREGATION
    LEUNG, L
    NACHMAN, R
    ANNUAL REVIEW OF MEDICINE, 1986, 37 : 179 - 186